View Financial HealthThis company has been acquiredThe company may no longer be operating, as it has been acquired. Find out why through their latest events.See Latest EventsThink Research 配当と自社株買い配当金 基準チェック /06Think Research配当金を支払った記録がありません。主要情報n/a配当利回り-9.6%バイバック利回り総株主利回り-9.6%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Jun 15Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million on June 13, 2024. The consideration of CAD 11.9 million, subject to standard adjustments, in addition to a performance earnout of up to CAD 2.5 million. The Transaction is expected to be highly accretive. The consideration is approximately CAD 3.9 million to be paid in cash at closing; CAD 2.5 million to be paid by way of the issuance of a promissory note at closing, secured against the shares of BioPharma and maturing on the first anniversary of the closing; approximately CAD 4.2 million to be paid by way of the issuance of Class A Subordinate Voting Shares of the Company at an issue price equal to the volume-weight average trading price for the 15 trading days ending as of June 12, 2024; CAD 1.25 million in value of Subordinate Voting Shares to be issued on closing based on the VWAP and placed into a four-month escrow for indemnity purposes; and up to CAD 2.5 million to be paid as an earn-out over the three years following the closing. Closing of the Transaction is subject to a number of standard conditions precedent, including conditional approval from the Toronto Stock Exchange. Bio Pharma generated approximately CAD 42.47 million ($31 million) of revenue in the trailing 12-month period. Fairmount Partners LP acted as exclusive financial advisor to Think Research in the Transaction.お知らせ • Nov 23Think Research Corporation to Report Q3, 2023 Results on Nov 27, 2023Think Research Corporation announced that they will report Q3, 2023 results at 9:30 AM, US Eastern Standard Time on Nov 27, 2023お知らせ • Oct 21Think Research Corporation Appoints Jeffrey Orridge to Its Board of DirectorsThink Research Corporation announced that it has appointed Jeffrey Orridge to its Board of Directors. Mr. Orridge is a proven leader with a background in Software-as-a-Service ("SaaS"), Artificial Intelligence ("AI"), brand marketing, and government. Mr. Orridge is currently the Chief Executive Officer of TVO Media Education Group, was the past Chair of Tiidal Gaming prior to its public listing, and also Commissioner of the CFL among other senior positions. Mr. Orridge joins an esteemed Think Research Board of Directors including, Dr. Eric Hoskins, Partner, Maverix Private Equity; Chair, Federal Advisory Council on the Implementation of National Pharmacare; former Minister of Health and Long Term Care, Ontario,Kirstine Stewart, author of bestselling leadership book Our Turn and Non-Executive Officer of Blink49Studios Inc.; Cindy Gray, Managing Director, Chief Executive Officer and the founder of 5 Quarters Investor Relations Inc. a Calgary-based consulting firm; Barry Reiter, Partner Bennett Jones LLP; Richard Wells, Chief Financial Officer of Waterton Global Resource Management Inc. and Partner, Finance at Kinterra Capital Corp.; Abe Schwartz, President of Schwartz Technologies Corporation; and Sachin Aggarwal, CEO of Think Research since 2010. Mr. Orridge's appointment is subject to the requisite clearing of his Personal Information Form in accordance with the rules of the TSX Venture Exchange.お知らせ • Aug 24Think Research Corporation to Report Q2, 2023 Results on Aug 29, 2023Think Research Corporation announced that they will report Q2, 2023 results at 7:15 AM, US Eastern Standard Time on Aug 29, 2023お知らせ • May 27Think Research Corporation, Annual General Meeting, Aug 11, 2023Think Research Corporation, Annual General Meeting, Aug 11, 2023.お知らせ • May 25Think Research Corporation to Report Q1, 2023 Results on May 29, 2023Think Research Corporation announced that they will report Q1, 2023 results at 5:15 PM, US Eastern Standard Time on May 29, 2023決済の安定と成長配当データの取得安定した配当: THKK.Fの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: THKK.Fの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Think Research 配当利回り対市場THKK.F 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (THKK.F)n/a市場下位25% (US)1.3%市場トップ25% (US)4.1%業界平均 (Healthcare Services)1.1%アナリスト予想 (THKK.F) (最長3年)n/a注目すべき配当: THKK.Fは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: THKK.Fは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: THKK.Fの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: THKK.Fが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/04/17 19:34終値2024/04/17 00:00収益2023/09/30年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Think Research Corporation 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Gavin FairweatherATB Cormark Historical (Cormark Securities)Douglas TaylorCanaccord GenuityDavid NewmanDesjardins Securities Inc.1 その他のアナリストを表示
お知らせ • Jun 15Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million on June 13, 2024. The consideration of CAD 11.9 million, subject to standard adjustments, in addition to a performance earnout of up to CAD 2.5 million. The Transaction is expected to be highly accretive. The consideration is approximately CAD 3.9 million to be paid in cash at closing; CAD 2.5 million to be paid by way of the issuance of a promissory note at closing, secured against the shares of BioPharma and maturing on the first anniversary of the closing; approximately CAD 4.2 million to be paid by way of the issuance of Class A Subordinate Voting Shares of the Company at an issue price equal to the volume-weight average trading price for the 15 trading days ending as of June 12, 2024; CAD 1.25 million in value of Subordinate Voting Shares to be issued on closing based on the VWAP and placed into a four-month escrow for indemnity purposes; and up to CAD 2.5 million to be paid as an earn-out over the three years following the closing. Closing of the Transaction is subject to a number of standard conditions precedent, including conditional approval from the Toronto Stock Exchange. Bio Pharma generated approximately CAD 42.47 million ($31 million) of revenue in the trailing 12-month period. Fairmount Partners LP acted as exclusive financial advisor to Think Research in the Transaction.
お知らせ • Nov 23Think Research Corporation to Report Q3, 2023 Results on Nov 27, 2023Think Research Corporation announced that they will report Q3, 2023 results at 9:30 AM, US Eastern Standard Time on Nov 27, 2023
お知らせ • Oct 21Think Research Corporation Appoints Jeffrey Orridge to Its Board of DirectorsThink Research Corporation announced that it has appointed Jeffrey Orridge to its Board of Directors. Mr. Orridge is a proven leader with a background in Software-as-a-Service ("SaaS"), Artificial Intelligence ("AI"), brand marketing, and government. Mr. Orridge is currently the Chief Executive Officer of TVO Media Education Group, was the past Chair of Tiidal Gaming prior to its public listing, and also Commissioner of the CFL among other senior positions. Mr. Orridge joins an esteemed Think Research Board of Directors including, Dr. Eric Hoskins, Partner, Maverix Private Equity; Chair, Federal Advisory Council on the Implementation of National Pharmacare; former Minister of Health and Long Term Care, Ontario,Kirstine Stewart, author of bestselling leadership book Our Turn and Non-Executive Officer of Blink49Studios Inc.; Cindy Gray, Managing Director, Chief Executive Officer and the founder of 5 Quarters Investor Relations Inc. a Calgary-based consulting firm; Barry Reiter, Partner Bennett Jones LLP; Richard Wells, Chief Financial Officer of Waterton Global Resource Management Inc. and Partner, Finance at Kinterra Capital Corp.; Abe Schwartz, President of Schwartz Technologies Corporation; and Sachin Aggarwal, CEO of Think Research since 2010. Mr. Orridge's appointment is subject to the requisite clearing of his Personal Information Form in accordance with the rules of the TSX Venture Exchange.
お知らせ • Aug 24Think Research Corporation to Report Q2, 2023 Results on Aug 29, 2023Think Research Corporation announced that they will report Q2, 2023 results at 7:15 AM, US Eastern Standard Time on Aug 29, 2023
お知らせ • May 27Think Research Corporation, Annual General Meeting, Aug 11, 2023Think Research Corporation, Annual General Meeting, Aug 11, 2023.
お知らせ • May 25Think Research Corporation to Report Q1, 2023 Results on May 29, 2023Think Research Corporation announced that they will report Q1, 2023 results at 5:15 PM, US Eastern Standard Time on May 29, 2023